With this extension, IXCHIQ®, the first vaccine against the chikungunya virus (CHIKV), is now available for administration for individuals 12 years of age and older in the European Union (EU).

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it has submitted a label extension application to the Medicines and Healthcare products Regulatory ...

The parasitic vine Cuscuta campestris grows by latching onto the stems and leaves of plants and inserting organs called ...

Chikungunya fever is a viral illness transmitted by mosquitoes. The name translates to "bends you up" or "stooped walk" due ...

Chikungunya cases have spiked substantially in La Réunion since early 2025, with 8,600 cases recorded and almost 3,000 new cases during the week of March 3 to 9, 2025 1. Similar to the 2005-2006 ...

A disabling mosquito-borne disease called chikungunya has killed two elderly people in the French Indian Ocean island of La ...

A new study conducted by a team of scientists at the Indian Institute of Technology (IIT) Roorkee have identified a potential drug for treating Chikungunya. Chikungunya is a mosquito-borne viral ...

IIT Roorkee researchers have discovered that Efavirenz, an HIV drug, may help treat Chikungunya by reducing virus replication in lab tests and mice models. While promising, clinical trials are needed ...

The study conducted by IIT Roorkee is supported by the Indian Council of Medical Research (ICMR). It has been published in a peer-reviewed scientific journal. Indian Institute of Technology (IIT ...

A hoarse voice is where the vocal cords become inflamed, causing a low, raspy voice. Potential causes of inflammation include laryngitis, vocal nodules, and acid reflux. This article discusses the ...

Delhi’s humid could result in an underestimation of the city's PM1 pollution by up to 20 per cent, according to a new study. Fine particulate matter could be absorbing moisture from Delhi’s ...